U-Blot® Research Grade RaxibacumabCat. No. WA3424Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade RaxibacumabCat. No. WA3424U-Blot® Research Grade RavulizumabCat. No. WA3423Request quote
Size: 50ug/100ug
U-Blot® Research Grade RavagalimabCat. No. WA3422Request quote
Size: 50ug/100ug
U-Blot® Research Grade rapaprutugCat. No. WA3421Request quote
Size: 50ug/100ug
U-Blot® Research Grade RanibizumabCat. No. WA3420Request quote
Size: 50ug/100ug
U-Blot® Research Grade RanevetmabCat. No. WA3419Request quote
Size: 50ug/100ug
U-Blot® Research Grade RamucirumabCat. No. WA3418Request quote
Size: 50ug/100ug
U-Blot® Research Grade RamaterceptCat. No. WA3417Request quote
Size: 50ug/100ug
U-Blot® Research Grade ramantamigCat. No. WA3416Request quote
Size: 50ug/100ug
U-Blot® Research Grade RalzapastotugCat. No. WA3415Request quote
Size: 50ug/100ug
U-Blot® Research Grade RaludotatugCat. No. WA3414Request quote
Size: 50ug/100ug
U-Blot® Research Grade RalpancizumabCat. No. WA3413Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598